As the COVID-19 situation develops, tax and regulatory specialists within the pharmaceutical & life sciences industry are increasingly facing complex challenges. Efficient and pragmatic solutions have to be realised, with fewer resources, in line with the changing local legislation.
The exchange of information is the best practice in this industry to support and inspire you in your daily business.
Continue reading PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA – Thursday 28. May 2020, 10:30 CEST
Animal nutrition company BIOMIN America was fined by more than $250’000 for coordinating sales of agricultural commodities to a company in Cuba without authorization from OFAC (US Office of Foreign Assets Controls).
Continue reading OFAC fined US subsidiary of Austrian ERBER Group after misinterpreting US Sanctions
As an effort to limit the impact of COVID-19, the Belgian government has introduced a temporary relief measure whereby certain goods imported into Belgium can benefit from a VAT and duty exemption.
A key condition to benefit from said exemption entails the importation by a so-called recognized healthcare institution (almost all Belgian hospitals qualify as such an institution).
Continue reading Will you change your supply chain to benefit from a VAT and duty free importation into Belgium?
In one of our previous posts we draw your attention to the upcoming deadline of May 26th, 2020 which was the date on which the MDR, i.e. the new EU regulation concerning medical devices was expected to be fully applicable.
Continue reading Great news for Swiss Medtech companies – Postponement of the application date of MDR
I would like to invite you to our next
webinar “PwC webinar – “Sourcing and manufacturing without side
effects!” which will be held on 31 March 2020 from 3:00 pm to 4:00 pm and
on 1 April 2020 from 9.00 am to 10.00 am.
We will also include some ITX Updates
related on COVID-19.
Continue reading PwC webinar – “Sourcing and manufacturing without side effects!” / COVID-19 ITX Update
the economic impact is unknown scenario planning is key
The impact and effects of COVID-19 are
being felt by businesses globally, and particularly in China where necessary
radical measures to contain the outbreak are impacting day to day life.
Continue reading Succeeding in Uncertainty: Responding to COVID-19
Medical devices suppliers conducting agreements for allowing hospitals to use free of charge their equipment might face both VAT and corporate tax adverse implications.
Continue reading Cutting edge tax implications for medical devices suppliers in Europe
gilt als Kernwert des Wirtschaftsstandorts Schweiz – und der MedTech-Branche.
Das Volks-Ja zur Steuerreform hat der innovativen Tätigkeit von Unternehmen wie
Ihrem eine neue Bedeutung verliehen. Auch andere nationale und internationale
Neuerungen der indirekten Steuern und Zölle sowie neue regulatorische
Rahmenbedingungen wirken sich 2020 auf die aktuelle und zukünftige Situation Ihres
Wie daraus ein echter
Mehrwert generiert werden kann, möchten wir gerne an unserem speziell der
MedTech Branche gewidmeten Event mit Ihnen diskutieren.
Continue reading Event: “Tax Engineering” für MedTech – 19. März 2020, PwC Luzern
1. The background in a nutshell
- Until 25th May 2020
all Medtech products that are admitted in Switzerland for the sale can be
distributed also in the EU.
- However, currently a
new treaty is negotiated by Switzerland and the EU Joint Committee in that
- In case the treaty is
not going to be concluded between Switzerland and the EU, all Medtech
companies based in Switzerland are considered as not being anymore part of the
EU. Indeed this treaty hangs by a
the latest developments of the Swiss-EU negotiations concerning the
Institutional Agreement and the Mutual Recognition Agreement (MRA),
Swiss Medtech companies should be preparing for the case in which MRA would
no longer apply to the medical devices after 26th May 2020.
Continue reading Swiss Medtech companies – action required for the sale of products in the EU as per May 2020 – Is your business ready for the upcoming changes?
On November 15, in Lugano we have been honored to host the annual Tax Forum, which represents for PwC the main tax event in the Ticino area. This year we had the pleasure to host, as guest speaker, the Federal Councilor Ignazio Cassis, head of the Federal Department of Foreign Affairs.
Continue reading Pharma & Life Sciences – The future is now: from digitalization in tax to AVIS28